Postvaccination immune-mediated hepatitis: what do we really know?

Lasagna, Angioletta; Pedrazzoli, Paolo; Bruno, Raffaele; Sacchi, Paolo

Lasagna, Angioletta; Pedrazzoli, Paolo; Bruno, Raffaele; Sacchi, Paolo.

Lasagna A; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.
Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.
Bruno R; Department of Internal Medicine & Medical Therapy, University of Pavia, Viale Camillo Golgi 19, Pavia, 27100, Italy.
Sacchi P; Department of Clinical Surgical Diagnostic & Pediatric Sciences, University of Pavia, Viale Camillo Golgi 19, Pavia, 27100, Italy.

Immunotherapy ; 15(9): 627-630, 2023 06.

Article in English | MEDLINE | ID: covidwho-2306840

ABSTRACT

ABSTRACT

Tweetable abstract The percentage of patients with immune-mediated vaccine-associated hepatitis is minimal compared with the number of patients vaccinated worldwide.

Subject(s)

Hepatitis, Autoimmune; Humans; Vaccination; Immunization

Keywords

AIH; COVID-19; autoimmune hepatitis; hepatitis; immune checkpoint inhibitors; molecular mimicry; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hepatitis, Autoimmune Topics: Vaccines Limits: Humans Language: English Journal: Immunotherapy Journal subject: Allergy and Immunology / Therapeutics Year: 2023 Document Type: Article Affiliation country: Imt-2023-0038

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google